Cargando…
Clarifying the role of adjuvant therapy after multi-agent neoadjuvant chemotherapy for patients with pancreatic ductal adenocarcinoma
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493801/ https://www.ncbi.nlm.nih.gov/pubmed/37701122 http://dx.doi.org/10.21037/tcr-23-720 |
| _version_ | 1785104545629601792 |
|---|---|
| author | Lan, Xiaoyang Abdel-Rahman, Omar |
| author_facet | Lan, Xiaoyang Abdel-Rahman, Omar |
| author_sort | Lan, Xiaoyang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10493801 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104938012023-09-12 Clarifying the role of adjuvant therapy after multi-agent neoadjuvant chemotherapy for patients with pancreatic ductal adenocarcinoma Lan, Xiaoyang Abdel-Rahman, Omar Transl Cancer Res Editorial Commentary AME Publishing Company 2023-08-21 2023-08-31 /pmc/articles/PMC10493801/ /pubmed/37701122 http://dx.doi.org/10.21037/tcr-23-720 Text en 2023 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Commentary Lan, Xiaoyang Abdel-Rahman, Omar Clarifying the role of adjuvant therapy after multi-agent neoadjuvant chemotherapy for patients with pancreatic ductal adenocarcinoma |
| title | Clarifying the role of adjuvant therapy after multi-agent neoadjuvant chemotherapy for patients with pancreatic ductal adenocarcinoma |
| title_full | Clarifying the role of adjuvant therapy after multi-agent neoadjuvant chemotherapy for patients with pancreatic ductal adenocarcinoma |
| title_fullStr | Clarifying the role of adjuvant therapy after multi-agent neoadjuvant chemotherapy for patients with pancreatic ductal adenocarcinoma |
| title_full_unstemmed | Clarifying the role of adjuvant therapy after multi-agent neoadjuvant chemotherapy for patients with pancreatic ductal adenocarcinoma |
| title_short | Clarifying the role of adjuvant therapy after multi-agent neoadjuvant chemotherapy for patients with pancreatic ductal adenocarcinoma |
| title_sort | clarifying the role of adjuvant therapy after multi-agent neoadjuvant chemotherapy for patients with pancreatic ductal adenocarcinoma |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493801/ https://www.ncbi.nlm.nih.gov/pubmed/37701122 http://dx.doi.org/10.21037/tcr-23-720 |
| work_keys_str_mv | AT lanxiaoyang clarifyingtheroleofadjuvanttherapyaftermultiagentneoadjuvantchemotherapyforpatientswithpancreaticductaladenocarcinoma AT abdelrahmanomar clarifyingtheroleofadjuvanttherapyaftermultiagentneoadjuvantchemotherapyforpatientswithpancreaticductaladenocarcinoma |